Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oligosaccharyltransferase complex subunit pseudogene 3 (OSTCP3) is categorized as a pseudogene related to the oligosaccharyltransferase (OST) complex. The OST complex in eukaryotes is responsible for protein N-glycosylation, an essential post-translational modification[1][3]. However, pseudogenes such as OSTCP3 do not encode functional proteins and are generally regarded as non-functional remnants of genes, though emerging evidence suggests some pseudogenes may regulate their protein-coding homologs via RNA-based mechanisms, including acting as microRNA sponges or generating small interfering RNAs that can modulate gene expression[2][4]. There is no evidence or established mechanism for OSTCP3 acting as a therapeutic target, receptor, enzyme, transporter, or as a biomarker for disease. Its clinical and biological relevance, if any, would likely be indirect and regulatory, not through encoded protein function.
Not applicable; not a protein drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oligosaccharyltransferase complex subunit pseudogene 3 (OSTCP3).